Previous close | 88.34 |
Open | 88.44 |
Bid | 85.52 x 800 |
Ask | 110.00 x 1100 |
Day's range | 88.44 - 89.54 |
52-week range | 70.74 - 97.97 |
Volume | |
Avg. volume | 518,521 |
Market cap | 4.523B |
Beta (5Y monthly) | 0.33 |
PE ratio (TTM) | 38.85 |
EPS (TTM) | 2.29 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 113.50 |
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.
MNSO, LSPD and HAE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 28, 2023.
Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.